Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CeaVac and TriAb in Minimal Metastatic Colorectal Cancer
NCT00033748Phase 2Completed
- Sponsor
- Cancer and Leukemia Group B
- Start
- Dec 2001
- Primary completion
- Mar 2007
- Modality
- Monoclonal Antibodies, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of 3H1 in colorectal cancer (CRC), sponsored by Cancer and Leukemia Group B. Started Dec 2001; status: completed.
02
Drugs
3H1
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00033748.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00033748.